Herpes simplex virus type 1 (HSV-1)-derived recombinant vectors for gene transfer and gene therapy

Methods in Molecular Biology

Volumn 1254, Issue , 2014, Pages 269-293

  Marconi, Peggy ^a   Fraefel, Cornel ^a   Epstein, Alberto L ^a  

^a NONE

Author keywords

Homologous recombination; HSV 1; Plasmid; Recombinant vectors; Transfection; Virus

Indexed keywords

DNA FRAGMENT; HERPESVIRUS VECTOR; PLASMID DNA; VIRUS DNA;

ARTICLE; DILUTION; DNA DETERMINATION; DNA ISOLATION; ELECTROPORATION; ESCHERICHIA COLI; EUKARYOTIC CELL; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS 1; HOMOLOGOUS RECOMBINATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PURIFYING SELECTION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS ATTENUATION; VIRUS PURIFICATION; VIRUS RECOMBINANT; VIRUS RECOMBINATION; VIRUS REPLICATION; VIRUS TITRATION;

EUKARYOTA; HUMAN HERPESVIRUS 1; MIRIDAE;

EID: 84922032345     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-2152-2_20     Document Type: Article

References (26)

1. Roizman B, Knipe DM (2001) Herpes simplex viruses and their replication. In: Knipe DM, Howley PM (eds) Fields virology. Lippincot, Williams and Wilkins, Philadelphia, PA, pp 2399-2460
2. Marozin S, Prank U, Sodeik B (2004) Herpes simplex virus type 1 infection of polarized epithelial cells requires microtubules and access to receptors present at cell-cell contact sites. J Gen Virol 85:775-786
3. Honess RW, Roizman B (1975) Regulation of herpesvirus macromolecular synthesis: sequential transition of polypeptide synthesis requires functional viral polypeptides. Proc Natl Acad Sci U S A 72:1276-1280
4. Batterson W, Roizman B (1983) Characterization of the herpes simplex virionassociated factor responsible for the induction of alpha genes. J Virol 46:371-377
5. Skepper JN, Whiteley A, Browne H et al (2001) Herpes simplex virus nucleocapsids mature to progeny virions by an envelopment → deenvelopment → reenvelopment pathway. J Virol 75:5697-5702
6. Deshmane SL, Fraser NW (1989) During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure. Virol 63:943-947
7. Farrell MJ, Dobson AT, Feldman LT (1991) Herpes simplex virus latency-associated transcript is a stable intron. Proc Natl Acad Sci U S A 88:790-794
8. Umbach JL, Kramer MF, Jurak I et al (2008) MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 454:780-783
9. Preston CM (2000) Repression of viral transcription during herpes simplex virus latency. J Gen Virol 8:1-19
10. Manservigi R, Argnani R, Marconi P et al (2007) Herpesvirus-based vectors for gene transfer, gene therapy, and the development of novel vaccines. In: Hefferon KL (ed) Virus expression vectors. Transworld Research Network, Kerala, India, pp 205-246
11. Krisky DM, Marconi PC, Oligino TJ et al (1998) Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications. Gene Ther 5:1517-1530
12. Wu N, Watkins SC, Schaffer PA et al (1996) Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22. J Virol 70: 6358-6369
13. Samaniego LA, Neiderhiser L, DeLuca NA (1998) Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J Virol 72: 3307-3320
14. Berto E, Bozac A, Marconi P (2005) Development and application of replicationincompetent HSV-1-based vectors. Gene Ther 12(Suppl 1):S98-S102
15. Krisky DM, Wolfe D, Goins WF et al (1998) Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Ther 5:1593-1603
16. Wolfe D, Mata M, Fink DJ (2009) A human trial of HSV-mediated gene transfer for the treatment of chronic pain. Gene Ther 16:455-460
17. Advani SJ, Weischelbaum RR, Whitley RJ et al (2002) Friendly fire: redirecting herpes simplex virus-1 for therapeutic applications. Clin Microbiol Infect 8:551-563
18. Argnani R, Lufino M, Manservigi M et al (2005) Replication-competent herpes simplex vectors: design and applications. Gene Ther 12(Suppl 1):S170-S177
19. Nawa A, Luo C, Zhang L et al (2008) Nonengineered, naturally oncolytic herpes simplex virus HSV1 HF-10: applications for cancer gene therapy. Curr Gene Ther 8:208-221
20. Gage PJ, Sauer B, Levine M et al (1992) A cell-free recombination system for site-specific integration of multigenic shuttle plasmids into the herpes simplex virus type 1 genome. J Virol 66:5509-5515
21. Rinaldi A, Marshall KR, Preston CM (1999) A non-cytotoxic herpes simplex virus vector which expresses Cre recombinase directs effi-cient site-specific recombination. Virus Res 65: 11-20
22. Stricklett PK, Nelson RD, Kohan DE (1998) Site-specific recombination using an epitope tagged bacteriophage P1 Cre recombinase. Gene 215:415-423
23. Krisky DM, Marconi PC, Oligino T et al (1997) Rapid method for construction of recombinant HSV gene transfer vectors. Gene Ther 4:1120-1125
24. Saeki Y, Ichikawa T, Saeki A et al (1998) Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors. Human Gene Ther 9:2787-2794
25. Tanaka M, Kagawa H, Yamanashi Y et al (2003) Construction of an excisable bacterial artificial chromosome containing a full-length infectious clone of herpes simplex virus type 1: viruses reconstituted from the clone exhibit wild-type properties in vitro and in vivo. J Virol 77:1382-1391
26. Warming S, Costantino N, Court DL et al (2005) Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res 33:e36